189 related articles for article (PubMed ID: 25319742)
1. Exhaled breath analysis for the diagnosis and assessment of endoluminal gastrointestinal diseases.
Markar SR; Wiggins T; Kumar S; Hanna GB
J Clin Gastroenterol; 2015 Jan; 49(1):1-8. PubMed ID: 25319742
[TBL] [Abstract][Full Text] [Related]
2. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
[TBL] [Abstract][Full Text] [Related]
4. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.
Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569
[TBL] [Abstract][Full Text] [Related]
6. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
7. Review article: breath analysis in inflammatory bowel diseases.
Kurada S; Alkhouri N; Fiocchi C; Dweik R; Rieder F
Aliment Pharmacol Ther; 2015 Feb; 41(4):329-41. PubMed ID: 25523187
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
Hanna GB; Boshier PR; Markar SR; Romano A
JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
[TBL] [Abstract][Full Text] [Related]
9. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
10. Mass-Spectrometry Analysis of Mixed-Breath, Isolated-Bronchial-Breath, and Gastric-Endoluminal-Air Volatile Fatty Acids in Esophagogastric Cancer.
Adam ME; Fehervari M; Boshier PR; Chin ST; Lin GP; Romano A; Kumar S; Hanna GB
Anal Chem; 2019 Mar; 91(5):3740-3746. PubMed ID: 30699297
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
12. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
[TBL] [Abstract][Full Text] [Related]
13. Volatile Markers for Cancer in Exhaled Breath-Could They Be the Signature of the Gut Microbiota?
Bhandari MP; Polaka I; Vangravs R; Mezmale L; Veliks V; Kirshners A; Mochalski P; Dias-Neto E; Leja M
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110724
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
[TBL] [Abstract][Full Text] [Related]
15. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
16. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer.
Markar SR; Wiggins T; Antonowicz S; Chin ST; Romano A; Nikolic K; Evans B; Cunningham D; Mughal M; Lagergren J; Hanna GB
JAMA Oncol; 2018 Jul; 4(7):970-976. PubMed ID: 29799976
[TBL] [Abstract][Full Text] [Related]
18. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.
Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA
Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596
[TBL] [Abstract][Full Text] [Related]
20. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
